Public Research Programme

Research is at the core of everything we do at the University of Plymouth.

Our rich research culture seeks to better understand the world we live in, and – for many – make a difference that will leave it better for future generations.

We are celebrating the impact of this work by opening up the often intriguing world of research, inviting the public, researchers, businesses, and students to hear the fascinating research stories.

Introduced by Professor Jerry Roberts, Deputy Vice-Chancellor for Research and Enterprise, we welcome you to our 2020 research-focused events.

Browse the events on offer and join us for captivating explorations of science, engineering, arts, culture, health, medicine and more.

<p>Research Festival hero</p>
Research Festival
<p>Mathew mat upton</p>
Inaugural Professorial Lectures

</p><div><div>Students on seminar</div></div><div><div>Large group of students sitting in the lecture hall at university and listening to their teacher. Focus on teacher's hand. Unrecognisable people.</div></div>

Public Research Lectures
<p>Background with Christmas balls - Soft focus<br></p>
Christmas Research Lecture

Inaugural Professorial Lectures

We are delighted to present the inaugural lectures from our academics who have been awarded their professorship as a mark of their esteemed research.

Celebrate their accomplishments in a special evening sharing their journey so far, providing the opportunity to hear their insight into the specialist topics their high-quality research investigates. 

Further information on future events will be available shortly.

Antibiotic resistance and the quest for discovery – Professor Mathew Upton

Inaugural Professorial Lecture | (Postponed)

Predictions indicate that by 2050, 10 million people per year will die from antibiotic resistant infections, igniting a new urgency to tackle this global crisis. 

Professor Mathew Upton reflects on his extensive microbiology research that focuses on discovering potential sources for antimicrobials that can be turned into the new classes of antibiotic, and his career so far including the launch of his spinout company, Amprologix.